Article: Sunlight Research™, Releases Its Amgen EPO Patents Report.(Report)

Sunlight Research™ - The Source for Patent Analysis (www.sunlightresearch.com) announced the release of its report analyzing Amgen, Inc.'s Erythropoietin (EPO) US patent portfolio (see also Biologics).

The Report analyzes the patent claims coverage of 38 US patents owned or controlled by Amgen (NASDAQ:AMGN), and explains how those patents do or do not cover the corresponding technology used in their commercial product Epogen. The technology focuses on recombinant erythropoietin, pharmaceutical compositions comprising erythropoietin, human erythropoietin gene sequences and the combination of erythropoietin with other proteins, such as stem cell factor.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!